mhurhangee/patent-ind-claim-en huggingface dataset:
Wheelset for a rail vehicle, with at least one wheelset shaft as well as with a first wheel and a second wheel, wherein a first tensioning element , by means of which the first wheel is detachably connected to the at least one wheelset shaft , is arranged at least between the first wheel and the at least one wheelset shaft , wherein the first tensioning element is tensioned against the first wheel and the at least one wheelset shaft by means of a first screw arranged in a first bore hole as well as further screws arranged in further bore holes, which run in parallel with a tensioning element longitudinal axis , characterised in that at least one first wedge sleeve is arranged at least around the first screw .
An indwelling device comprising: a main body ; a sheet-like attaching member for indwelling the main body on a body surface of a living body; and a plate-like intermediate member (50, 50A to 50G) that is configured to be elastically deformable and is stacked between the main body and the attaching member , wherein the intermediate member (50, 50A to 50G) includes a base , and a first extending portion and a second extending portion that extend in parallel from the base , a first fixing portion (60, 60A to 60C) fixed to the attaching member from the base to the first extending portion is provided on a surface of the intermediate member (50, 50A to 50G) on a side of the attaching member , a second fixing portion (70, 70A to 70C) fixed to the main body from the base to the second extending portion is provided on a surface of the intermediate member (50, 50A to 50G) on a side of the main body , the first extending portion is not fixed to the main body , and the second extending portion is not fixed to the attaching member , wherein one of the first extending portion and the second extending portion is a central piece (56, 56A-C) protruding from a central portion in a width direction of the base , and another one of the first extending portion and the second extending portion is a pair of arm pieces (58, 58A-C) protruding from both sides in the width direction of the base . a main body ; a sheet-like attaching member for indwelling the main body on a body surface of a living body; and a plate-like intermediate member (50, 50A to 50G) that is configured to be elastically deformable and is stacked between the main body and the attaching member , wherein the intermediate member (50, 50A to 50G) includes a base , and a first extending portion and a second extending portion that extend in parallel from the base , a first fixing portion (60, 60A to 60C) fixed to the attaching member from the base to the first extending portion is provided on a surface of the intermediate member (50, 50A to 50G) on a side of the attaching member , a second fixing portion (70, 70A to 70C) fixed to the main body from the base to the second extending portion is provided on a surface of the intermediate member (50, 50A to 50G) on a side of the main body , the first extending portion is not fixed to the main body , and the second extending portion is not fixed to the attaching member , wherein one of the first extending portion and the second extending portion is a central piece (56, 56A-C) protruding from a central portion in a width direction of the base , and another one of the first extending portion and the second extending portion is a pair of arm pieces (58, 58A-C) protruding from both sides in the width direction of the base .
Method to evaluate the quality of cork, comprising: - supplying a plurality of calibration samples made of cork, both not contaminated and contaminated by a fungal metabolism; - dividing the calibration samples into a plurality of quality categories as a function of the attack by the fungal metabolism; - spectroscopic sampling analysis in the near-infrared of said calibration samples to identify, from the processing of the respective characteristic spectrum, identifying reference parameters of each of said quality categories and correlated to the attack by the fungal metabolism; - spectroscopic analysis in the near-infrared band of at least one product made of cork, which must be evaluated, to detect a characteristic spectrum of said cork of said product ; - processing said characteristic spectrum of said product made of cork to evaluate at least one conditioning parameter of the quality of said cork correlated to the attack by the fungal metabolism; - comparing said conditioning parameter with said reference parameters, to identify whether said product belongs to one of said quality categories; - selection of said product as a function of said comparison, to associate it to one of said quality categories. - supplying a plurality of calibration samples made of cork, both not contaminated and contaminated by a fungal metabolism; - dividing the calibration samples into a plurality of quality categories as a function of the attack by the fungal metabolism; - spectroscopic sampling analysis in the near-infrared of said calibration samples to identify, from the processing of the respective characteristic spectrum, identifying reference parameters of each of said quality categories and correlated to the attack by the fungal metabolism; - spectroscopic analysis in the near-infrared band of at least one product made of cork, which must be evaluated, to detect a characteristic spectrum of said cork of said product ; - processing said characteristic spectrum of said product made of cork to evaluate at least one conditioning parameter of the quality of said cork correlated to the attack by the fungal metabolism; - comparing said conditioning parameter with said reference parameters, to identify whether said product belongs to one of said quality categories; - selection of said product as a function of said comparison, to associate it to one of said quality categories.
A process for the production of a fiber cement sheet, at least comprising the steps of: (a) providing a fiber cementitious slurry at least comprising fibers, cement and water, (b) continuously discharging said fiber cementitious slurry on an endless water-permeable transport belt , (c) removing excess of water from said fiber cementitious slurry through said water-permeable transport belt by suction, so as to form a fiber cement sheet with a predetermined thickness wherein said suction takes place in at least three consecutive zones with different under-pressures, wherein the consecutive zones have increasing under-pressures, wherein the under-pressure of a first of said zones ranges between 15 and 65 mbar, in a second of said zones between 65 and 200 mbar, in a third of said zones between 200 to 550 mbar, and characterized in that said suction takes place in at least four consecutive with different under-pressures, wherein the consecutive zones have increasing under-pressures, wherein the under-pressure of a first of said zones ranges between 15 and 65 mbar, in a second of said zones between 65 and 200 mbar, in a third of said zones between 200 to 550 mbar, and in a fourth of said zones between 550 mbar and 850 mbar. (a) providing a fiber cementitious slurry at least comprising fibers, cement and water, (b) continuously discharging said fiber cementitious slurry on an endless water-permeable transport belt , (c) removing excess of water from said fiber cementitious slurry through said water-permeable transport belt by suction, so as to form a fiber cement sheet with a predetermined thickness wherein said suction takes place in at least three consecutive zones with different under-pressures, wherein the consecutive zones have increasing under-pressures, wherein the under-pressure of a first of said zones ranges between 15 and 65 mbar, in a second of said zones between 65 and 200 mbar, in a third of said zones between 200 to 550 mbar, and
An apparatus for generating a signal waveform for biological stimulation, comprising a signal input unit for acquiring and inputting an external signal from an external environment, an output waveform generation unit for generating and outputting a first biological stimulation signal wave modulated with at least one of a frequency component, an envelope component and an amplitude component included in the external signal acquired by the signal input unit and/or synchronized with an output timing of the external signal, and a first coil for generating a magnetic field by feeding of the first biological stimulation signal wave, wherein: the output waveform generation unit is constructed so as to generate the first biological stimulation signal wave subjected to frequency modulation by at least one of the frequency component, the envelope component and the amplitude component included in the external signal, and a frequency of the first biological stimulation signal wave is a high frequency wave of 200MHz to 300MHz. a signal input unit for acquiring and inputting an external signal from an external environment, an output waveform generation unit for generating and outputting a first biological stimulation signal wave modulated with at least one of a frequency component, an envelope component and an amplitude component included in the external signal acquired by the signal input unit and/or synchronized with an output timing of the external signal, and a first coil for generating a magnetic field by feeding of the first biological stimulation signal wave, wherein: the output waveform generation unit is constructed so as to generate the first biological stimulation signal wave subjected to frequency modulation by at least one of the frequency component, the envelope component and the amplitude component included in the external signal, and a frequency of the first biological stimulation signal wave is a high frequency wave of 200MHz to 300MHz. the output waveform generation unit is constructed so as to generate the first biological stimulation signal wave subjected to frequency modulation by at least one of the frequency component, the envelope component and the amplitude component included in the external signal, and a frequency of the first biological stimulation signal wave is a high frequency wave of 200MHz to 300MHz.
An apparatus for treatment of body areas with a light beam comprising: a light source module comprising a body containing at least one low-level laser light source and a lens, the light source and lens being configured in combination to produce a collimated, light beam elongated in cross-section and the apparatus being configured to illuminate a treatment area of a surface with the collimated light beam , the treatment area being external to the light source module; and a scanning mechanism attached to the body of the light source module and configured to impart predetermined motion to the body of the light source module, thereby to impart the predetermined motion to the low-level laser light source and the lens of the light source module as well, the predetermined motion comprising at least rotation of the body of the light source module about an axis of the collimated, elongated light beam emitted from the light source module. a light source module comprising a body containing at least one low-level laser light source and a lens, the light source and lens being configured in combination to produce a collimated, light beam elongated in cross-section and the apparatus being configured to illuminate a treatment area of a surface with the collimated light beam , the treatment area being external to the light source module; and a scanning mechanism attached to the body of the light source module and configured to impart predetermined motion to the body of the light source module, thereby to impart the predetermined motion to the low-level laser light source and the lens of the light source module as well, the predetermined motion comprising at least rotation of the body of the light source module about an axis of the collimated, elongated light beam emitted from the light source module.
A super absorbent polymer comprising: a base polymer powder including a cross-linked polymer obtained by crosslinking polymerization of a water-soluble ethylenically unsaturated monomer having an acidic group of which at least a part is neutralized in the presence of an encapsulated foaming agent; and a surface cross-linked layer that is further cross-linked from the cross-linked polymer and is formed on the base polymer powder, wherein the encapsulated foaming agent has a structure including a core containing hydrocarbon and a shell surrounding the core and formed of a thermoplastic resin, and has an average diameter before expansion, measured as disclosed in the specification, of 5 to 20 μ m, a maximum expansion size in air, measured as disclosed in the specification, of 50 to 190 μ m and a maximum expansion ratio in air, measured as disclosed in the specification, of 8.5 to 10 times, wherein a ratio (M 1 /M 0 *100) of the super absorbent polymer particle (M 1 ) having three or more pores with a diameter, as measured through scanning electron microscope, of 20 to 200 μ m on the surface to the super absorbent polymer particle (M 0 ) having a particle diameter, as measured by sieving, of 300 to 425 μ m is 10% or more, and wherein a distilled water absorption capacity is at least 150 g/g, and wherein the ratio (M 1 /M 0 *100), the distilled water absorption capacity and the CRC are measured as disclosed on the specification. wherein the encapsulated foaming agent has a structure including a core containing hydrocarbon and a shell surrounding the core and formed of a thermoplastic resin, and has an average diameter before expansion, measured as disclosed in the specification, of 5 to 20 μ m, a maximum expansion size in air, measured as disclosed in the specification, of 50 to 190 μ m and a maximum expansion ratio in air, measured as disclosed in the specification, of 8.5 to 10 times, wherein a ratio (M 1 /M 0 *100) of the super absorbent polymer particle (M 1 ) having three or more pores with a diameter, as measured through scanning electron microscope, of 20 to 200 μ m on the surface to the super absorbent polymer particle (M 0 ) having a particle diameter, as measured by sieving, of 300 to 425 μ m is 10% or more, and wherein a distilled water absorption capacity is at least 150 g/g, and wherein the ratio (M 1 /M 0 *100), the distilled water absorption capacity and the CRC are measured as disclosed on the specification.
An enzyme catalyzed desorption process for releasing CO 2 gas from an ion-rich solution containing bicarbonate ions, the process comprising: providing carbonic anhydrase or variants or analogues thereof in the ion-rich solution such that in a desorption unit the carbonic anhydrase or variants or analogues thereof is allowed to flow with the ion-rich solution while promoting conversion of the bicarbonate ions into CO 2 gas and generating an ion-depleted solution; controlling an initial concentration of the bicarbonate ions in the ion-rich solution below a denaturation threshold to avoid or reduce denaturing the carbonic anhydrase in the desorption unit; controlling a temperature of the ion-rich solution below an enzymatic denaturing temperature threshold to avoid denaturing the carbonic anhydrase in the desorption unit; and releasing the CO 2 gas and the ion-depleted solution from the desorption unit; wherein the ion-rich solution comprises at least one compound selected from the following: tertiary amines, tertiary alkanolamines, tertiary amino acids, carbonates, 2-amino-2-methyl-1-propanol (AMP), 2-amino-2-hydroxymethyl-1,3-propanediol (TRIS), and derivatives of piperidine or piperazine which are substituted by at least one alkanol group; and wherein the carbonic anhydrase is provided in an amount sufficient to enable a reduction in regeneration energy from 10% to 60% compared to use of a carbamate-forming solution. providing carbonic anhydrase or variants or analogues thereof in the ion-rich solution such that in a desorption unit the carbonic anhydrase or variants or analogues thereof is allowed to flow with the ion-rich solution while promoting conversion of the bicarbonate ions into CO 2 gas and generating an ion-depleted solution; controlling an initial concentration of the bicarbonate ions in the ion-rich solution below a denaturation threshold to avoid or reduce denaturing the carbonic anhydrase in the desorption unit; controlling a temperature of the ion-rich solution below an enzymatic denaturing temperature threshold to avoid denaturing the carbonic anhydrase in the desorption unit; and releasing the CO 2 gas and the ion-depleted solution from the desorption unit; wherein the ion-rich solution comprises at least one compound selected from the following: tertiary amines, tertiary alkanolamines, tertiary amino acids, carbonates, 2-amino-2-methyl-1-propanol (AMP), 2-amino-2-hydroxymethyl-1,3-propanediol (TRIS), and derivatives of piperidine or piperazine which are substituted by at least one alkanol group; and wherein the carbonic anhydrase is provided in an amount sufficient to enable a reduction in regeneration energy from 10% to 60% compared to use of a carbamate-forming solution.
A lithium silicate blank for a dental restoration, the lithium silicate blank comprising lithium metasilicate crystals as the main crystalline phase, wherein the blank has a holder to fix it in a machine.
A solid or semi-solid oral delivery dosage form comprising: a first component that comprises a thickening agent; a second component that comprises an active ingredient in the form of a powder, granule, bead, minitablet, pellet, nanoparticle, or a combination thereof; and wherein the first component and the second component are contained in a sealed container. a first component that comprises a thickening agent; a second component that comprises an active ingredient in the form of a powder, granule, bead, minitablet, pellet, nanoparticle, or a combination thereof; and wherein the first component and the second component are contained in a sealed container.
Cleaning apparatus for a sensor , in particular of a vehicle , the cleaning device comprising: - at least one cleaning nozzle designed to apply a cleaning fluid (RF, DL, F) to a surface (AR) to be cleaned of the at least one sensor , - a fluid supply means , in particular a fluid valve or a pump , designed to selectively supply the cleaning fluid (RF) to the cleaning nozzle , - an actuator for generating a cleaning movement (BR) of the cleaning nozzle , - the cleaning apparatus having a switching means for controlling the actuator such that - the cleaning movement (BR) can be generated independently of the fluid supply means , characterized in that - the actuator is designed as a fluidic pressure cylinder , in particular a pneumatic pressure cylinder , having a pressure input for receiving an actuating pressure (PA) for generating the cleaning movement (BR), pressurized cleaning fluid (RF, DL, F) being received at the pressure input . - at least one cleaning nozzle designed to apply a cleaning fluid (RF, DL, F) to a surface (AR) to be cleaned of the at least one sensor , - a fluid supply means , in particular a fluid valve or a pump , designed to selectively supply the cleaning fluid (RF) to the cleaning nozzle , - an actuator for generating a cleaning movement (BR) of the cleaning nozzle , - the cleaning apparatus having a switching means for controlling the actuator such that - the cleaning movement (BR) can be generated independently of the fluid supply means , - the actuator is designed as a fluidic pressure cylinder , in particular a pneumatic pressure cylinder , having a pressure input for receiving an actuating pressure (PA) for generating the cleaning movement (BR), pressurized cleaning fluid (RF, DL, F) being received at the pressure input .
An agent which elevates p38γ activity, or the activity of a variant of p38γ, in neurons of a subject, for use in treating or preventing a neurological condition mediated by a tau-dependent signalling complex in neurons of a subject, wherein the agent elevates p38γ activity or the activity of a variant of p38γ is an agent that: (a) elevates the amount of p38γ in the neuron; and/or (b) elevates the amount of a variant of p38γ in the neuron; and/or (c) elevates the amount of p38γ activation in the neuron; and/or (d) elevates the amount of activation of the variant of p38γ in the neuron, wherein p38γ activity or the activity of a variant of p38γ causes disruption of the tau-dependent signalling complex and is phosphorylation of tau at T205, wherein a variant of p38γ is a protein that phosphorylates tau at T205 and comprises a PDZ interaction motif comprising the amino acid sequence EPTL (SEQ ID NO: 8) or ETAL (SEQ ID NO: 32), and wherein the agent comprises a nucleic acid sequence, a nucleic acid analogue, a protein, or a peptide. wherein the agent elevates p38γ activity or the activity of a variant of p38γ is an agent that: (a) elevates the amount of p38γ in the neuron; and/or (b) elevates the amount of a variant of p38γ in the neuron; and/or (c) elevates the amount of p38γ activation in the neuron; and/or (d) elevates the amount of activation of the variant of p38γ in the neuron, (a) elevates the amount of p38γ in the neuron; and/or (b) elevates the amount of a variant of p38γ in the neuron; and/or (c) elevates the amount of p38γ activation in the neuron; and/or (d) elevates the amount of activation of the variant of p38γ in the neuron, wherein p38γ activity or the activity of a variant of p38γ causes disruption of the tau-dependent signalling complex and is phosphorylation of tau at T205, wherein a variant of p38γ is a protein that phosphorylates tau at T205 and comprises a PDZ interaction motif comprising the amino acid sequence EPTL (SEQ ID NO: 8) or ETAL (SEQ ID NO: 32), and wherein the agent comprises a nucleic acid sequence, a nucleic acid analogue, a protein, or a peptide.